Drugs / anti-BCMA CAR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03455972 | Feb 2018 → Dec 2027 expected | — | The First Affiliated Hospital of Soochow University | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-BCMA CAR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03455972 ↗ |
| Modality | Cell therapy | “anti-BCMA CAR T cells” NCT03455972 ↗ |
| Route | Intravenous | “participants will get the T cells through the IV within 3 days” NCT03455972 ↗ |